Cargando…

Molecular and Clinical Aspects of Targeting the VEGF Pathway in Tumors

Tumor angiogenesis is a complex process resulting from many signals from the tumor microenvironment. From preclinical animal models to clinical trials and practice, targeting tumors with antiangiogenic therapy remains an exciting area of study. Although many scientific advances have been achieved, l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korpanty, Grzegorz, Sullivan, Laura A., Smyth, Elizabeth, Carney, Desmond N., Brekken, Rolf A.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902148/ https://www.ncbi.nlm.nih.gov/pubmed/20628530 http://dx.doi.org/10.1155/2010/652320

Ejemplares similares

VEGF and Pleiotrophin Modulate the Immune Profile of Breast Cancer
por: Lynn, Kristi D., et al.
Publicado: (2010)

The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer
por: Dineen, Sean P, et al.
Publicado: (2008)

Phosphorylation of Akt and ERK1/2 Is Required for VEGF-A/VEGFR2-Induced Proliferation and Migration of Lymphatic Endothelium
por: Dellinger, Michael T., et al.
Publicado: (2011)

r84, a Novel Therapeutic Antibody against Mouse and Human VEGF with Potent Anti-Tumor Activity and Limited Toxicity Induction
por: Sullivan, Laura A., et al.
Publicado: (2010)

Localization of VEGF to Vascular ECM Is an Important Aspect of Tumor Angiogenesis
por: You, Weon-Kyoo, et al.
Publicado: (2017)

Targeting the VEGF Pathway in Osteosarcoma
por: Assi, Tarek, et al.
Publicado: (2021)

TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy
por: Dayoub, Adam S., et al.
Publicado: (2020)

Perspectives on Hypoxia Signaling in Tumor Stroma
por: Zhang, Yuqing, et al.
Publicado: (2021)

Cytokine Levels Correlate with Immune Cell Infiltration after Anti-VEGF Therapy in Preclinical Mouse Models of Breast Cancer
por: Roland, Christina L., et al.
Publicado: (2009)

Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects
por: Teschke, Rolf
Publicado: (2018)

Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma
por: Barone, Amy, et al.
Publicado: (2014)

Phosphatidylserine-targeting antibody induces M1 macrophage polarization, promotes myeloid derived suppressor cell differentiation and boosts tumor-specific immunity
por: Huang, Xianming, et al.
Publicado: (2013)

Molecular and Cellular Pathways as a Target of Therapeutic Hypothermia: Pharmacological Aspect
por: Han, Hyung Soo, et al.
Publicado: (2012)

VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside
por: Arjaans, Marlous, et al.
Publicado: (2016)

Editorial: Molecular Aspects of Mucopolysaccharidoses
por: Węgrzyn, Grzegorz, et al.
Publicado: (2022)

Inhibiting Growth of Human Triple-Negative Breast Cancer Cells by Activating Mutant p53 Protein Alone or in Combination With a Phosphatidylserine-Targeting Antibody
por: Liang, Yayun, et al.
Publicado: (2021)

Some aspects of molecular diagnostics in Lynch syndrome
por: Kurzawski, Grzegorz
Publicado: (2006)

CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target
por: Malik, Shivani, et al.
Publicado: (2021)

Targeting phosphatidylserine synergizes with immune checkpoint blockade by inducing de novo tumor specific immunity
por: Huang, Xianming, et al.
Publicado: (2015)

In vivo solid tumor targeting with recombinant VEGF-diphtheria immunotoxin
por: Hosseininejad-Chafi, Mohammad, et al.
Publicado: (2022)

Biomarkers That Currently Affect Clinical Practice in Lung Cancer: EGFR, ALK, MET, ROS-1, and KRAS
por: Korpanty, Grzegorz J., et al.
Publicado: (2014)

Emerging molecular targets and therapy for cholangiocarcinoma
por: Kayhanian, Hamzeh, et al.
Publicado: (2017)

Notch and VEGF pathways play distinct but complementary roles in tumor angiogenesis
por: Hernandez, Sonia L, et al.
Publicado: (2013)

Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy
por: Wu, Jing-biao, et al.
Publicado: (2018)

Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease
por: Muniyandi, Anbukkarasi, et al.
Publicado: (2023)

Hydroxyapatite Use in Spine Surgery—Molecular and Clinical Aspect
por: Litak, Jakub, et al.
Publicado: (2022)

Molecular Aspects of Regional Pain Syndrome
por: Baronio, Manuela, et al.
Publicado: (2020)

Phytochemicals Targeting VEGF and VEGF-Related Multifactors as Anticancer Therapy
por: Parveen, Amna, et al.
Publicado: (2019)

SPARC: a matricellular regulator of tumorigenesis
por: Arnold, Shanna A., et al.
Publicado: (2009)

SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression
por: Abouelnazar, Fatma A., et al.
Publicado: (2023)

Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment
por: Yopp, Adam, et al.
Publicado: (2014)

Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway
por: Fu, Zhongping, et al.
Publicado: (2015)

Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors
por: Smyth, Elizabeth C, et al.
Publicado: (2014)

SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-β1 activity
por: Rivera, Lee B., et al.
Publicado: (2011)

Stromal TGFβR2 signaling: a gateway to progression for pancreatic cancer
por: Hagopian, Moriah M, et al.
Publicado: (2014)

Targeting VEGF-VEGFR Pathway by Sunitinib in Peripheral Primitive Neuroectodermal Tumor, Paraganglioma and Epithelioid Hemangioendothelioma: Three Case Reports
por: Prochilo, Tiziana, et al.
Publicado: (2013)

The VEGF signaling pathway in cancer: the road ahead
por: Stacker, Steven A., et al.
Publicado: (2013)

Phosphaturic mesenchymal tumors: radiological aspects and suggested imaging pathway
por: Hussein, Mohsin A. M., et al.
Publicado: (2021)

Progress of molecular targeted therapy for head and neck cancer in clinical aspects
por: Nakano, Kenji
Publicado: (2021)

Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer
por: Belzile, Olivier, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q77n6q321kc4f9p71v5oecira4